Immune Square, Inc is here to satisfy the needs of drug developing researchers and risk-taking bio-venture companies. Immune Square, Inc. has been developing advanced platforms for producing the recombinant proteins as well as single-domain antibodies (sdAd) since its establishment in Daegu, South Korea in 2019.5.24,
We provide not only decision making evidence for the therapeutic drugs but fast, high quality, and cost-effective recombinant protein production services to the customers as well. We offer step-by-step tailored services for the recombinant proteins including the large scale manufacturing scalabilities. Our services can give a competitive benefit the project from gene synthesis to protein expression, purification, and eventually stable cell line for large-scale production.